Parallel Advisors’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $456K | Buy |
14,020
+3,447
| +33% | +$111K | 0.01% | 761 |
|
|
2025
Q4 | $372K | Buy |
10,573
+5,719
| +118% | +$203K | 0.01% | 799 |
|
|
2025
Q3 | $128K | Buy |
4,854
+3,036
| +167% | +$90.6K | ﹤0.01% | 1285 |
|
|
2025
Q2 | $48.2K | Buy |
1,818
+455
| +33% | +$12K | ﹤0.01% | 1744 |
|
|
2025
Q1 | $32.9K | Buy |
1,363
+536
| +65% | +$16.9K | ﹤0.01% | 1883 |
|
|
2024
Q4 | $33.3K | Sell |
827
-216
| -21% | -$12.3K | ﹤0.01% | 1888 |
|
|
2024
Q3 | $66K | Buy |
+1,043
| New | +$61.2K | ﹤0.01% | 1462 |
|
|
2024
Q2 | – | Sell |
-197
| Closed | -$16.2K | – | 3436 |
|
|
2024
Q1 | $16.2K | Buy |
+197
| New | +$8.77K | ﹤0.01% | 2095 |
|
|
2022
Q3 | – | Sell |
-98
| Closed | – | – | 3541 |
|
|
2022
Q2 | $0 | Sell |
98
-1,455
| -94% | -$3.6K | ﹤0.01% | 3410 |
|
|
2022
Q1 | $5K | Hold |
1,553
| – | – | ﹤0.01% | 2324 |
|
|
2021
Q4 | $7K | Hold |
1,553
| – | – | ﹤0.01% | 2280 |
|
|
2021
Q3 | $10K | Hold |
1,553
| – | – | ﹤0.01% | 2083 |
|
|
2021
Q2 | $9K | Hold |
1,553
| – | – | ﹤0.01% | 2068 |
|
|
2021
Q1 | $10K | Hold |
1,553
| – | – | ﹤0.01% | 1937 |
|
|
2020
Q4 | $9K | Hold |
1,553
| – | – | ﹤0.01% | 1842 |
|
|
2020
Q3 | $9K | Hold |
1,553
| – | – | ﹤0.01% | 1796 |
|
|
2020
Q2 | $11K | Buy |
+1,553
| New | +$10.3K | ﹤0.01% | 1690 |
|
|
2020
Q1 | – | Sell |
-1,568
| Closed | -$13K | – | 2672 |
|
|
2019
Q4 | $13K | Hold |
1,568
| – | – | ﹤0.01% | 1626 |
|
|
2019
Q3 | $11K | Buy |
+1,568
| New | +$11.6K | ﹤0.01% | 1646 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 2316 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 2312 |
|
Other funds holding VKTX
VCM
VPM
